Mental Illness Benefits at the Workplace

Employees need their employers to share the cost of mental health treatment as a bona fide employee benefit.

According to the National Alliance on Mental Illness (NAMI), 20% of adults in the U.S. will experience mental health problems each year, yet less than half of those diagnosed receive treatment. Why? The almighty dollar, of course.

Mental health care is expensive, and many adults, even those gainfully employed and with tremendous benefits, cannot afford the ongoing costs necessary to treat the many common mental health issues afflicting society today.

Anxiety, depression, substance abuse, PTSD, eating issues, phobias, bipolar disorder. These were an issue pre-pandemic; in 2019, the National Institute of Mental Health (NIMH) reported nearly 52 million adults experienced some form of mental illness. According to the Centers for Disease Control (CDC), depression interferes with physical and mental job tasks between 20% and 35% of the time.

But these conditions alone are not the only problem.

Mental health disorders often lead to other medical problems. For example, NAMI reports individuals with depression are 40% more likely to develop cardiovascular or other metabolic disorders, and 32% of adults with mental illness also experience a substance abuse disorder. In addition, the CDC reports that “the costs for treating people with mental health disorders and other physical conditions are two to three times higher than for those without co-occurring illnesses.”

I see this as a public health crisis the workplace must engage in, considering the average adult spends roughly one-third of their waking hours at work — when they aren’t absent.

Mental health and comorbidities significantly impact employee absence, as employee wellbeing and absenteeism are inextricably linked. Beyond that, productivity suffers when mental illness goes untreated. Known as “presenteeism,” mental health costs employers significantly when employees are at work but not focused. Simply put, workers struggling with mental health issues get less done.

According to research from the National Safety Council and the National Opinion Research Center at the University of Chicago, employees with mental health problems cost their employers nearly $5,000 per year in lost workdays, increased turnover, and higher health care costs.

So, what can employers do? Staying the course is not an option, and it shouldn’t be if the end goal is a healthier, safer, and more productive workforce.

Employees need their employers to share the cost of mental health treatment as a bona fide employee benefit. Supplemental benefit products can help accomplish this, whereas mental health and drug or alcohol issues have been exclusions previously. Therefore, removing these exclusions is a positive step forward.

Riders are also a possibility, enabling employees to elect the coverage. However, with a rider, employees receive only a streamlined version of benefits that would otherwise be more robust and flexible if it were a separate policy.

Another option is expanding Employee Assistance Plans (EAPs), covering a practical and sufficient number of doctor visits instead of one or two that have been the standard practice. However, most EAP plans are not subject to COBRA as they are, in essence, referral sources instead of actual health plans.

We need to innovate.

While these options are all well and good, building insurance products where mental health services are a part of the plans — such as inside critical illness insurance (CI) product — is the future. This is important for several reasons, including the high value placed on this employee offering. In addition, the insurance carrier will not be subject to adverse selection like it can be as a rider.

To make this a reality, carriers and employers must come to the table.

In a recent announcement from Thrive, the behavior-change technology company founded by Arianna Huffington, and the Society for Human Resource Management (SHRM), Johnny C. Taylor, Jr., SHRM President, and CEO, stated, “Now more than ever, employers must commit and provide adequate resources to support their employees’ successful mental health and wellbeing. It’s not just good for their businesses – it’s also the right thing to do.”

Thrive and SHRM brought more than 80 companies together, including brands such as Marriott International, CVS Health, and Microsoft, to pledge that “The times are uncertain. Our commitment to mental health is not… That’s why we’ve come together to pledge to continue prioritizing our employees’ wellbeing and mental health through the uncertain times ahead — and maintain our investments and commitments in this critical area.”

In most employees’ minds, employers must realize this situation is real; mental health coverage is second only to traditional health and dental care. So, they must find a broker or consultant willing to be the collaborative link between themselves and insurance carriers – one who can be creative in this partnership to help carriers deliver innovative solutions.

As for carriers, they must realize this is their opportunity to help employers shine and build stronger relationships with their employees. Carriers that design customizable products with offerings such as mental health care built-in will ultimately differentiate themselves in a marketplace where product differentiation is critical. This strategy will also allow them to charge an appropriately higher premium that will offset any adverse selection concerns, which may be a problem for carriers that create standalone mental health care products.

“There are several things an insurance carrier can do to make mental health a bigger priority in their critical illness products, including covering mental health screenings under wellness benefits, providing EAP resources at the time of the claim, or adding mental health conditions as insured benefits under their plan,” said Matt Ennis, Director, Strategy, Product and Marketing at Reliance Standard.

Finally, brokers must keep fighting the good fight, demanding this of carriers. If they want to see a better result for their clients, brokers must engage; be that creative, collaborative partners; and be intentional about finding – and helping create – the ancillary products their clients need and deserve.

“While mental health conditions are a challenge as they cannot be diagnosed definitively with blood tests or x-rays, this is a challenge the industry must come together to solve. Mental health greatly impacts a person’s likelihood of being disabled or dying prematurely,” Ennis concluded. It’s a problem where the employer, employee, carrier, and broker are aligned in their interests – an excellent starting point.”

What’s the worst thing that could happen? Doing nothing. And the best?

Successful employers; productive, healthy employees; trusted brokers and consultants; and profitable carriers.

Positives all around.

The Positives from COVID-19

Over the last twenty months, what we have witnessed is nothing short of unprecedented: unprecedented deaths, unprecedented business closings, and unprecedented personal disruption for millions of employees and their families. My heart goes out to those who suffered the loss of a loved one, health, job, or financial security. I know the feeling firsthand. I will never forget that phone call that notified me that my family member had passed away.

These losses created disruptions in the daily lives of families and their plans for their future. Thankfully, I have seen employees and their families react to their lack of financial wellness, which has made for an unprecedented demand for life insurance, critical illness, and other products to fill the gaps in protecting their families.

As I reflect on the last twenty months, I’m more excited today than ever before about serving as an intermediary for employers and their employees. My role is to ask questions, take notes, go out to the market and build the best possible solution for the employer and their employees.

Are your employees paying too much for their voluntary benefits? Most likely.

Contact me at jhyman@jeffhyman.net for a Cost-Benefit Analysis of your voluntary benefit products and your core medical plan.

Kicking You When You’re Down

For cancer patients, the road from diagnosis to survivorship feels like a never-ending parade of medical appointments: surgeries, bloodwork, chemotherapy, radiation treatments, scans. The routine is time-consuming and costly. So, when hospitals charge patients double-digit parking fees, patients often leave the garage demoralized.

Iram Leon vividly remembers the first time he went for a follow-up MRI appointment at Dell Seton Medical Center in Austin, Texas, after he had been treated at another hospital for a brain tumor.

The medical news was good: His stage 2 tumor was stable. The financial news was not. When he sat down at the receptionist’s desk to check out, Leon was confronted by a bold, red-lettered sign on the back of her computer that read: “WE DO NOT VALIDATE PARKING.”

Below that all-caps statement was a list of parking rates, starting with $2 for a 30-minute visit and maxing out at $28 a day. Lose your ticket? Then you could pay $27 for an hour.

“To this day, I remember that sign,” Leon, 40, said of the 2017 appointment, which he posted about on Facebook. “These patients were people who were coming in for various types of cancer treatment. These were people who were keenly aware of their own mortality, and yet the sign was screaming at them, ‘We do not validate parking.’” (Hospital officials did not respond to requests for comment about their parking policy.)

JulieAnn Villa, who was diagnosed in March with her third bout of cancer, estimates she has spent “thousands of dollars” on parking fees during her years of treatment and follow-up care. She faces a transportation dilemma every time she commutes 6 miles to Chicago’s Northwestern Memorial Hospital from her apartment. Should she take public transit? Call a pandemic surge-rate Uber? Ask a friend to drive her? Or pay $12 to $26 (with validation) to park in a garage where each floor is named after singers like Dolly Parton and Frank Sinatra?

She was hospitalized for multiple days in April after spending 23 hours alone in an overburdened ER, because she didn’t want friends to pay to wait with her. “I almost drove myself, and I’m so glad I didn’t,” Villa said. “That would have been expensive.”

Long a source of frustration for patients, the cost of parking while in cancer treatment is finally drawing national scrutiny from oncology researchers and even some hospital administrators.

“If you want to rile up patients or caregivers or family members, just bring up parking costs,” said Dr. Fumiko Chino, a radiation oncologist at Memorial Sloan Kettering Cancer Center in New York who studies the “financial toxicity” of cancer treatment, including costs not covered by insurance, such as parking fees.

Chino, who enrolled in medical school after her husband died of a rare neuroendocrine cancer in 2007, added, “For people who have to pay $15 to $18 every single time, which is what I remember paying, it really feels like the last straw, frankly — like kicking you when you’re down.”

Public transit is possible for some cancer patients in larger cities, but not for those too ill or immunocompromised. Others have accessibility issues. Many must travel to get care, making driving the best option.

Parking fees can have implications for more than just the patient. “Some patients say, ‘This is the reason I didn’t participate in a clinical trial, because I couldn’t afford the parking,’” Chino said.

At a time when hospitals and drug companies are under increasing pressure to diversify clinical trial populations, testing only patients who can afford high parking fees is problematic, Chino said.

There are some pilot programs to improve access to drug trials, and some charities, such as the Leukemia & Lymphoma Society, offer travel grants, but accessibility remains a substantial barrier to cancer care, said Elizabeth Franklin, president of the nonprofit Cancer Support Community, which offers financial aid to patients and advocates in Washington, D.C., for “patient-centered” health policies.

“The true definition of a patient-centered health care system,” Franklin said, is one that allows patients to choose the best means of transportation. “It’s not making them go into debt because they’ve had to pay a ton of money for parking each time they go to the clinic or the hospital.”

Chino and colleagues published a short study in July showing that some cancer patients pay $1,680 over the course of treatment.

According to readership statistics released in late March, the study was the most read and downloaded article in JAMA Oncology last year, and it continues to prompt a lively social media response. A thread on Reddit has logged more than 1,100 comments, including many from patients in other countries voicing surprise at U.S. parking policies.

The researchers calculated the cost to park at 63 National Cancer Institute-designated cancer centers while receiving the standard number of treatments for each of three types of cancers: node-positive breast cancer, head and neck cancers, and acute myeloid leukemia, or AML. They did not calculate costs for follow-up appointments, blood draws, routine scans and immune-boosting injections.

They found that, while 20 of the hospitals provided free parking for all cancer patients, the other 43 had widely varying fees.

“The range was $0 to $800 for breast cancer,” Chino said. “That’s huge, and it’s not like the person who’s paying $800 is necessarily getting any better treatment.” The maximum charges for a standard course of therapy for head and neck cancer were $665 and for AML, $1,680.

Practices should change, Chino said, “to alleviate this strain for our patients.”

Of the 63 hospitals, including those where parking is free for cancer patients, 54% offered free parking for chemotherapy and 68% for radiation treatment.

The top daily parking rate, according to the researchers, is $40 at New York’s Mount Sinai Hospital. (A spokesperson for Mount Sinai declined to comment.) Chino’s own institution, Memorial Sloan Kettering, is not far behind; parking at one of its main garages begins at $12 an hour and maxes out at $36 a day. A spokesperson for the hospital said some locations do offer free parking, and all patients can apply for aid to cover parking costs.

A few colleagues scoffed when Chino said she was researching parking charges, she said, but a growing number of mostly younger oncologists are concerned about indirect costs that contribute to the financial toxicity of cancer.

“It seems ethically incorrect to nickel-and-dime patients for parking charges,” a trio of doctors wrote last year in an editorial published by the American Society of Clinical Oncologists. They acknowledge that most top cancer hospitals are in urban centers, where parking costs are often high and third-party agencies may operate the garages. “Nevertheless, in 2020, with our multibillion-dollar cancer center budgets, we as health care systems should do everything we can to help patients and caregivers,” the editorial said.

City of Hope National Medical Center in Los Angeles is one of the 20 NCI-designated hospitals that do not charge patients for parking. Dr. Vijay Trisal, a surgical oncologist who serves as City of Hope’s chief medical officer, takes pride in that distinction.

“Charging cancer patients for parking is like a knife in the back,” he said. “We can’t control copays, but we can control what patients pay for parking.”

While Trisal would never want a patient to choose City of Hope for the free parking alone, he acknowledges the policy gives his hospital a competitive advantage.

“You would not believe how many patients have said to me, ‘Thank you for not charging for parking,’” he said.

Build The Voluntary Benefits Plan That Employees Will Purchase

In my conversations with CEOs and CFOs, I often hear why our employees did not purchase the voluntary benefits that they offered at open enrollment through XYZ company. My response is, let me review your summary plan documents on your most recent open enrollment to understand your offering better.

As we all know, the pricing of insurance products may vary depending on different factors. What are some of the critical factors that make up the rate?

Total expenses are developed based on the internal expectations of commission, premium taxes, administrative costs, and overhead. The expense assumptions outlined below represent an example of a  new case:

Claims Adjudication 1.75%

Commissions 15%-20%

Premium Tax 2%

Overhead 10%

Profit Margin of 8%

Loss Ratio 55-60%

Also, at the case level, expense assumptions may vary.

Click on the link below to listen to my recent conversation with @stevewatson, CFO as we discuss heaped, level, or net commissions.

http://trendbreakers.buzzsprout.com/1122509/5507068-54-building-worksite-employee-benefits-net-of-commissions-jeff-hyman-principal-consultant-jlh-consulting

Insurance Stocks Still Struggling YTD

The Accident and Health segment is +2.01% YTD, but the Life segment is down 28.91% YTD.

Aflac, the leading provider of supplemental insurance in the U.S., closed Friday at $36.75, down 30.48% YTD.

Prudential, closed at $63.34, down 30.76%.

Unum stock closed at $18.15, down 37.83%.

Lincoln National Corp closed at $37.30, down 36.94%.

Met Life closed at $38.10, down 25.01%.

Hartford Financial closed at $41.48, down 31.74%

Allstate closed at $94.00, down 16.09%.

Voya Financial closed at $49.19, down 19.33%.

Sun Life (U.S.) closed at $39.63, down 13.03%.

Principal Financial closed at $44.40, down 18.61%.

Manulife Life closed at $13.96, down 31.10%.

Aegon (owns Transamerica) closed at $3.04, down 32.89%.

Health Insurance Companies (Stock)

United HealthCare Group closed at $298.30, up 2.32%

Cigna closed at $180.25, down 11.48%

CVS (owns Aetna) closed at $74.16, down $14.74%.

Anthem closed at $270.49, down 10.44%.

Humana closed at $392.14, up 6.99%.

Global Brokers

Marsh & McLennan, the world’s largest broker, closed at $114.62, up 2.88%.

Aon closed at $207.17, down 0.54%.

Willis Towers Watson closed at $211.52, up 4.74%.

Arthur J. Gallagher closed at $103.93, up 9.14%

Brown & Brown closed at $40.45, up 14.99%

Insurance Stocks Keep Getting Hammered

Aflac market cap has fallen $13 billion since February 3, 2020. Aflac stock was trading at $52.01 at the close on February 3. Today, March 12, 2020, Aflac stock closed at $32.39 per share, with a market cap of $26.69 billion. YTD, Aflac stock is down 41.11%.

Prudential, known as a piece of the rock, has seen its stock drop 51.17% YTD. Their stock closed at $91.50 on February 3, 2020, and closed today at $47.64 with a market cap of $23.01 billion.

Unum has seen its stock drop 54.22% YTD. Unum stock closed on February 3, 2020, at $27.03 and closed today at $14.55 and a market cap of $3.55 billion.

Lincoln National Corp has seen its stock drop 60.89% YTD. On February 3, 2020, LNC stock closed at $54.32 and closed today at $24.14 and a market cap of $6.23 billion.

Met Life has seen its stock drop from $49.69 at the close of trading on February 3, 2020, to closing today at $29.02 and a market cap of $30.50 billion. Met Life stock is down 45.18% YTD.

Hartford Financial has seen its stock drop from $60.14 at the close of trading on February 3, 2020, and closed today at $41.15 and a market cap of $16.17 billion. Hartford stock is down 34.08% YTD.

Allstate has seen its stock drop from $119.05 at the close of trading on February 3, 2020, to $86.08 at the end of trading today. Allstate stock is down YTD 25.72%.

Voya Financial has seen its stock drop from $60.40 at the close of trading on February 3, 2020, to $40.56 at the end of trading today with a market cap of $5.37 billion.

Global Brokers stock has also struggled year-to-date.

Marsh & McLennan, the world’s largest broker, is down 16.99% YTD after closing today at $95.27. Marsh & McLennan has a market cap of $49.86 billion at the end of trading today.

Aon, who announced it was acquiring Willis Tower Watson, closed at the end of trading today at $174.67, down 16.90% YTD. Aon has a market cap of $42.84 billion.

Willis Towers Watson closed at $175.00 today, down almost 15% YTD. WTW has a market cap of $24.23 billion at the close of trading today.

Arthur J. Gallagher closed today at $87.20, down 8.70% YTD. Gallagher has a market cap of $17.88 billion.

Brown & Brown closed today at $37.99, down 4.1% YTD. Brown & Brown has a market cap of 11.71%.

Insurance Stocks Struggling

Aflac market cap has fallen $13 billion since February 3, 2020. Aflac stock was trading at $52.01 at the close on February 3. Today, March 12, 2020, Aflac stock closed at $32.39 per share, with a market cap of $26.69 billion. YTD, Aflac stock is down 41.11%.

Prudential, known as a piece of the rock, has seen its stock drop 51.17% YTD. Their stock closed at $91.50 on February 3, 2020, and closed today at $47.64 with a market cap of $23.01 billion.

Unum has seen its stock drop 54.22% YTD. Unum stock closed on February 3, 2020, at $27.03 and closed today at $14.55 and a market cap of $3.55 billion.

Lincoln National Corp has seen its stock drop 60.89% YTD. On February 3, 2020, LNC stock closed at $54.32 and closed today at $24.14 and a market cap of $6.23 billion.

Met Life has seen its stock drop from $49.69 at the close of trading on February 3, 2020, to closing today at $29.02 and a market cap of $30.50 billion. Met Life stock is down 45.18% YTD.

Hartford Financial has seen its stock drop from $60.14 at the close of trading on February 3, 2020, and closed today at $41.15 and a market cap of $16.17 billion. Hartford stock is down 34.08% YTD.

Allstate has seen its stock drop from $119.05 at the close of trading on February 3, 2020, to $86.08 at the end of trading today. Allstate stock is down YTD 25.72%.

Voya Financial has seen its stock drop from $60.40 at the close of trading on February 3, 2020, to $40.56 at the end of trading today with a market cap of $5.37 billion.

Global Brokers stock has also struggled year-to-date. Marsh & McLennan, the world’s largest broker, is down 16.99% YTD after closing today at $95.27. Marsh & McLennan has a market cap of $49.86 billion at the end of trading today.

Aon, who announced it was acquiring Willis Tower Watson, closed at the end of trading today at $174.67, down 16.90% YTD. Aon has a market cap of $42.84 billion.

Willis Towers Watson closed at $175.00 today, down almost 15% YTD. WTW has a market cap of $24.23 billion at the close of trading today.

Arthur J. Gallagher closed today at $87.20, down 8.70% YTD. Gallagher has a market cap of $17.88 billion.

Brown & Brown closed today at $37.99, down 4.1% YTD. Brown & Brown has a market cap of $11.71 billion.